Back
Nektar Therapeutics Stock Predictions
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
73
NKTR
Nektar Therapeutics
Last Price:
$63.68
Seasonality Move:
1.26%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Nektar Therapeutics Stock Forecast
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 30.4% based on the past 31 years of stock performance.
-
Nektar Therapeutics has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
-
Is Nektar Therapeutics Stock Undervalued?The current Nektar Therapeutics [NKTR] share price is $56.00. The Score for NKTR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Nektar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Nektar Therapeutics has on average historically risen by 30.4% based on the past 31 years of stock performance.
Nektar Therapeutics Stock Rating
Buy
73
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics overpriced?
-
Nektar Therapeutics has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
Nektar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
nektar.com
52-Week Data
52-Week High:
66.92
52-Week Low:
6.48
Prediction Charts
Market Cap:
968.8M
Price in USD:
56.00
Volume:
8.7M
Beta:
1.26
Technical Analysis
SMA50:
44.49
SMA100:
51.54
SMA200:
36.46
52-Wk Change:
433.34%
Stock Predictions
-
Is Nektar Therapeutics stock public?Yes, Nektar Therapeutics is a publicly traded company.
-
What is the Nektar Therapeutics stock quote today?The Nektar Therapeutics stock price is 56.00 USD today.
-
How to buy Nektar Therapeutics stock online?You can buy Nektar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-22 | 36.92 | 36.53 | 37.99 | 35.77 |
| Jan-23 | 37.82 | 37.11 | 39.75 | 36.72 |
| Jan-26 | 36.77 | 37.18 | 37.50 | 35.95 |
| Jan-27 | 37.40 | 38.03 | 38.36 | 36.82 |
| Jan-28 | 37.78 | 35.91 | 38.40 | 35.82 |
| Jan-29 | 35.65 | 35.23 | 36.20 | 34.82 |
| Jan-30 | 35.02 | 37.33 | 37.70 | 33.40 |
| Feb-2 | 37.29 | 38.12 | 39.43 | 37.05 |
| Feb-3 | 38.06 | 38.86 | 39.13 | 37.64 |
| Feb-4 | 38.44 | 37.64 | 38.93 | 36.13 |
| Feb-5 | 37.60 | 35.12 | 38.47 | 34.90 |
| Feb-6 | 35.18 | 36.81 | 37.26 | 34.47 |
| Feb-9 | 36.88 | 37.07 | 37.66 | 35.60 |
| Feb-10 | 47.15 | 56.00 | 56.76 | 47.05 |
Nektar Therapeutics Earnings
Nektar Therapeutics Earnings Report: Per Share Nektar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Nektar Therapeutics Forecast Revenue Growth
Nektar Therapeutics Stock Analysis: Historical quarterly revenues per share for Nektar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.08 per share, and a decrease next year of $2.48 per share.
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.